Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: My take on all this (IMO)
That only works if the SP can be depressed after the RS and the ability to do that via Swartz and any other insider is limited since you've RS'ed their holdings as well........Either way, RS or not, TPL would have to either make a cash offer for an absolute takeover of PTSC's assets or have the outstanding increased in a joint merger of sorts......IMO.....
Share
New Message
Please login to post a reply